[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biomx Ltd (PHGE)

Biomx Ltd (PHGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 734
  • Shares Outstanding, K 1,594
  • Annual Sales, $ 0 K
  • Annual Income, $ -36,200 K
  • EBIT $ -31 M
  • EBITDA $ -28 M
  • 60-Month Beta 1.02
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -8.17
  • Most Recent Earnings $-5.51 on 11/12/25
  • Next Earnings Date 05/21/26 [--]
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Products

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-6.27
  • Growth Rate Est. (year over year) +16,033.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3608 +3.66%
on 05/19/26
1.8000 -79.22%
on 04/20/26
-1.4660 (-79.67%)
since 04/17/26
3-Month
0.3608 +3.66%
on 05/19/26
8.1000 -95.38%
on 03/09/26
-4.8560 (-92.85%)
since 02/19/26
52-Week
0.3608 +3.66%
on 05/19/26
14.7117 -97.46%
on 07/14/25
-10.1178 (-96.44%)
since 05/19/25

Most Recent Stories

More News
BiomX’s Zorronet Puts Full AI Command-and-Control in the Palm of Your Hand

NETANYA, Israel, May 06, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE: PHGE) (“BiomX” or the “Company”) today announced that its Zorronet subsidiary has launched a secure mobile application...

PHGE : 0.3740 (-18.80%)
Zorronet Delivers 98% Success in Israel Railways Pilot, Awarded Framework Supply Agreement for AI-Powered Detection Systems

NETANYA, Israel, April 16, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”) today highlighted the successful deployment of its Zorronet subsidiary in collaboration...

PHGE : 0.3740 (-18.80%)
BiomX Accelerates Defense Technology Buildout with DFSL Acquisition

NETANYA, Israel, April 13, 2026 (GLOBE NEWSWIRE) -- BiomX Inc . (NYSE: PHGE) (“BiomX" or the “Company") today announced that it has accelerated the exercise of its  previously disclosed exclusive...

PHGE : 0.3740 (-18.80%)
BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications

NETANYA, Israel and REHOVOT, Israel, April 10, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (the “Company”) today announced that it has completed the acquisition of 100% of Zorronet...

PHGE : 0.3740 (-18.80%)
BiomX Obtains Option to Acquire Control of Israeli Laser-Radar Counter-Drone System

NETANYA, Israel, March 31, 2026 (GLOBE NEWSWIRE) -- BiomX Inc . (NYSE American: PHGE) today announced that it has entered into an option agreement to acquire control of DFSL , a developer of proprietary...

PHGE : 0.3740 (-18.80%)
BiomX Adds Former Mossad Deputy to Advisory Board

NETANYA, Israel, March 30, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE), today announced the appointment of Dr. Ehud (Udi) Levi to its newly formed Advisory Board.  Dr. Levi will support...

PHGE : 0.3740 (-18.80%)
BiomX Inc. Received NYSE American Notification Letter Regarding Stockholders' Equity Deficiency

NETANYA, Israel, March 27, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (the “Company”) today announced that on March 25, 2026, the Company received a notice from the staff of NYSE...

PHGE : 0.3740 (-18.80%)
BiomX Launches Security Subsidiary in Israel and Will Initially Invest Over $3 million In Its Operations

NETANYA, Israel, March 26, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) today announced the launch of X Security & Defense LTD., a new wholly-owned subsidiary. The company will finance...

PHGE : 0.3740 (-18.80%)
BiomX CEO Issues Letter to Stockholders

CEO Letter to Stockholders highlights the Company's strategic and financial reset designed to strengthen BiomX in the near term and unlock future growth opportunities

PHGE : 0.3740 (-18.80%)
BiomX Names Michael Oster as Chief Executive Officer, David Rokach Chief Financial Officer to Support Next Phase of Growth

Seasoned financial leaders join BiomX to support strategic execution and advancement of the company

PHGE : 0.3740 (-18.80%)

Business Summary

BiomX Ltd is a clinical stage microbiome company. It engages in developing both natural and engineered phage cocktails designed to target and destroy bacteria which affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as IBD, PSC and cancer. BiomX Ltd, formerly known as...

See More

Key Turning Points

3rd Resistance Point 0.5233
2nd Resistance Point 0.4881
1st Resistance Point 0.4311
Last Price 0.3740
1st Support Level 0.3389
2nd Support Level 0.3037
3rd Support Level 0.2467

See More

52-Week High 14.7117
Fibonacci 61.8% 9.2297
Fibonacci 50% 7.5362
Fibonacci 38.2% 5.8428
Last Price 0.3740
52-Week Low 0.3608

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.